(Q39029106)

8 September 2017

1 reference

title

The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting (English)

1 reference

seropositive rheumatoid arthritis

8 September 2017

1 reference

1 reference

3

Lars Klareskog

1 reference

8 September 2017

1

Vivianne Malmström

1 reference

8 September 2017

2

Anca I Catrina

1 reference

8 September 2017

language of work or name

1 reference

5 December 2016

1 reference

Nature Reviews Immunology

8 September 2017

published in

1 reference

8 September 2017

volume

17

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

60-75

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Immune complexes can trigger specific, T cell-dependent, autoanti-IgG antibody production in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-keratin antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Occupational exposure to textile dust increases the risk of rheumatoid arthritis: results from a Malaysian population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Celiac disease: Autoimmunity in response to food antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Molecular mechanisms of congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A prediction rule for the development of arthritis in seropositive arthralgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Stromal transcriptional profiles reveal hierarchies of anatomical site, serum response and disease and identify disease specific pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the tim

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Expanding antigen-specific regulatory networks to treat autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

21 January 2018

Rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The influence of ACPA status and characteristics on the course of RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Genetics of rheumatoid arthritis contributes to biology and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Chromatin marks identify critical cell types for fine mapping complex trait variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Autoimmune diseases - connecting risk alleles with molecular traits of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Immune complexes regulate bone metabolism through FcRγ signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Smoking and overweight determine the likelihood of developing rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: Participation of TNF-α, IL-1β and CXCL1/KC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Smoking induces transcription of the heat shock protein system in the joints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Identification of New Citrulline-Specific Autoantibodies, Which Bind to Human Arthritic Cartilage, by Mass Spectrometric Analysis of Citrullinated Type II Collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRI.2016.124

31 March 2020

12 December 2020

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.124

On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939

31 March 2020

1 reference

12 December 2020

The immunopathology of joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

1 reference

12 December 2020

Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase

1 reference

12 December 2020

Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8.

1 reference

12 December 2020

The intestine and rheumatism.

1 reference

12 December 2020

Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease

1 reference

12 December 2020

The origin of rheumatoid arthritis

1 reference

12 December 2020

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

12 December 2020

A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.

1 reference

12 December 2020

Rheumatoid factors antedating clinical rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2016.124

1 reference

8 September 2017

1 reference